Table 1 Affinity of PD-1 antibody to hPD-1, cynoPD-1, and mPD-1 measured by SPR.

From: CS1003, a novel human and mouse cross-reactive PD-1 monoclonal antibody for cancer therapy

Antigen

Ligand

ka (1/Ms)

kd (1/s)

KD (M)

hPD-1

CS1003

5.97×105

3.66×10−3

6.13×10−9

cynoPD-1

CS1003

8.09×105

7.07×10−3

8.74×10−9

mPD-1

CS1003

3.23×105

1.29×10−3

3.99×10−9

hPD-1

Pembrolizumab

8.79×105

2.28×10−3

2.59×10−9